Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...

Tris Pharma announced positive topline results from the ALLEVIATE-2 phase III clinical trial of investigational cebranopadol to treat moderate-to-severe acute pain after bunionectomy surgery. Axonal ...

Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

For decades, scientists have focused on amyloid plaques—abnormal clumps of misfolded proteins that accumulate between neurons ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of ...

A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...

Motor neuron diseases are a group of fatal progressive disorders that rob the body and brain of the ability to function.

MND Scotland says that around 450 people in the country are living with Motor Neurone Disease. One symptom that can easily be ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty speaking ...

Experts warn that excessive saliva, or drooling, could be a potential indicator of motor neurone disease (MND), a condition ...

The experts say if you notice that you produce a "lot of saliva (drool)", then this could indicate motor neurone disease (MND ...

ATH-434-201 is a 77-patient, randomized, double-blinded, placebo-controlled effort – the “gold standard” of study designs.